|
GB0913672D0
|
|
Glitazones
|
|
GB0910944D0
|
|
Respiratory disease treatment
|
|
GB0910123D0
|
|
Compounds
|
|
GB0908942D0
|
|
Compounds
|
|
GB0908941D0
|
|
Compounds
|
|
GB0908317D0
|
|
Pharmaceutical compounds and compositions
|
|
GB0908069D0
|
|
Pharmaceutical compounds and compositions
|
|
GB0908068D0
|
|
Enzyme inhibitors
|
|
GB0906854D0
|
|
Compounds
|
|
GB0906853D0
|
|
Compounds
|
|
GB0903945D0
|
|
Pharmaceutical compounds and compositions
|
|
GB0902648D0
|
|
Pharmaceutical compounds and compositions
|
|
GB0902651D0
|
|
Pharmaceutical compounds and compositions
|
|
GB0901831D0
|
|
Respiratory disease treatment
|
|
GB0901832D0
|
|
Respiratory disease treatment
|
|
GB0901616D0
|
|
Enzyme inhibitors
|
|
WO2009090399A1
|
|
Indoles active on crth2 receptor
|
|
GB0823568D0
|
|
Respiratory disease treatment
|
|
WO2009060206A1
|
|
3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use
|
|
GB0820436D0
|
|
Compounds
|
